The FDA has approved the first vaccine for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD as a result of respiratory syncytial virus (RSV) in infants, from birth through 6...
Part 2 of the series on COVID-19 presented by Prof. Schmitt, Prof. Weil-Olivier, and Prof. Altmann.
This Global Health Cast was produced with the unconditional support of an educational grant from Novavax ()
Forty-sixth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:54 EG.5 variant 02:34 What to do when you catch COVID-19 05:58 Unusual dengue surge in Bangladesh 08:28...
Forty-fifth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:52 COVID-19 cases update 03:37 How long do COVID-19 symptoms last 05:34 Who should take Paxlovid, and how...
Part 1 of the series on COVID-19 presented by Prof. Schmitt, Prof. Weil-Olivier, and Dr. Karafillakis. 00:00 Introduction 01:46 Attitude changes to COVID-19 during the pandemic 09:46 Is there an inverse relationship...
Forty-fourth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:35 Dengue epidemiology 01:00 Transmission between mosquitoes and humans 01:58 Dengue risk by area 02:41...
Forty-third Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:35 Dengue phases 01:30 Clinical signs of dengue fever 02:25 Antibody disease enhancement 03:05 Diseases...
Forty-second Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 00:35 Dengue definition 02:18 Dengue history 03:55 Flavivirus 05:00 Global distribution of Flaviviruses 06:28...
The European Medicines Agency (EMA) has created a concept paper that addresses the need to establish a guideline on the quality aspects of messenger RNA (mRNA) vaccines, emphasizing the number of clinical trial...